| Serial Number | 86778596 |
| Word Mark | BIS-RNAI |
| Filing Date | Monday, October 5, 2015 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, December 23, 2019 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 27, 2016 |
| Goods and Services | pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection; pharmaceuticals, biosimilars and biological preparations for medical and therapeutic purposes for use in the treatment of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection |
| Pseudo Mark | BIS RNAI; BIS RNA INTERFERENCE; BIS RIBONUCLEIC ACID INTERFERENCE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 8, 2015 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Alnylam Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Party Name | Alnylam Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Event Date | Event Description |
| Monday, December 23, 2019 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Monday, December 23, 2019 | ABANDONMENT - NO USE STATEMENT FILED |
| Wednesday, May 29, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED |
| Tuesday, May 28, 2019 | EXTENSION 5 GRANTED |
| Wednesday, May 22, 2019 | EXTENSION 5 FILED |
| Tuesday, May 28, 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, May 22, 2019 | TEAS EXTENSION RECEIVED |
| Friday, November 23, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED |
| Wednesday, November 21, 2018 | EXTENSION 4 GRANTED |
| Wednesday, November 21, 2018 | EXTENSION 4 FILED |
| Wednesday, November 21, 2018 | TEAS EXTENSION RECEIVED |
| Tuesday, April 3, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED |
| Friday, March 30, 2018 | EXTENSION 3 GRANTED |
| Friday, March 30, 2018 | EXTENSION 3 FILED |
| Friday, March 30, 2018 | TEAS EXTENSION RECEIVED |
| Tuesday, November 21, 2017 | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED |
| Friday, November 17, 2017 | EXTENSION 2 GRANTED |
| Friday, November 17, 2017 | EXTENSION 2 FILED |
| Friday, November 17, 2017 | TEAS EXTENSION RECEIVED |
| Tuesday, May 23, 2017 | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED |
| Friday, May 19, 2017 | EXTENSION 1 GRANTED |
| Friday, May 19, 2017 | EXTENSION 1 FILED |
| Friday, May 19, 2017 | TEAS EXTENSION RECEIVED |
| Tuesday, November 22, 2016 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, September 27, 2016 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 7, 2016 | NOTICE OF PUBLICATION |
| Friday, August 19, 2016 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Saturday, August 6, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, August 5, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, August 5, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, August 1, 2016 | ASSIGNED TO LIE |
| Tuesday, July 26, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, January 27, 2016 | NON-FINAL ACTION MAILED |
| Saturday, January 23, 2016 | NON-FINAL ACTION WRITTEN |
| Friday, January 22, 2016 | ASSIGNED TO EXAMINER |
| Thursday, October 8, 2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, October 8, 2015 | NEW APPLICATION ENTERED IN TRAM |